Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of Vascular Effects of Rosiglitazone.

NCT00154011 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.

NCT NCT00154011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00154011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of Vascular Effects of Rosiglitazone.
Lead sponsor
Technische Universität Dresden
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2005
Completion date
June 30, 2006
Enrollment
24
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy subjects